Copyright
©The Author(s) 2024.
World J Clin Cases. Oct 26, 2024; 12(30): 6361-6373
Published online Oct 26, 2024. doi: 10.12998/wjcc.v12.i30.6361
Published online Oct 26, 2024. doi: 10.12998/wjcc.v12.i30.6361
Pro-inflammatory (demyelination) chemokines | Cell type that produces chemokine | Chemokine function | Anti-inflammatory (remyelination) chemokines | Cell type that produces chemokine | Chemokine function |
TNF-α | Astrocytes | Promotes demyelination and oligodendrocyte pathology | TGF-β | Microglia (M2) | Promotes differentiation of different cell types during repair |
(iNOS+) | Microglia (M1) | Promotes the M1 phenotype, a pro-inflammatory state and induces phagocytosis | Insulin-like growth factor-1 | 1 Astrocytes; 2 Microglia (M2) | Regenerative role that promotes remyelination by promoting differentiation of different cell types such as oligodendrocytes |
TREM-2 | Microglia (M2) | Cell surface receptor that clears myelin debris and promotes phagocytosis | Fibroblast growth factor 2 | 1 Astrocytes; 2 Microglia (M2) | Regenerative role that promotes remyelination by promoting differentiation of different cell types such as oligodendrocytes |
Arg-1+ | Microglia (M2) | Promotes the M2 phenotype, an anti-inflammatory state |
- Citation: Medina R, Derias AM, Lakdawala M, Speakman S, Lucke-Wold B. Overview of emerging therapies for demyelinating diseases. World J Clin Cases 2024; 12(30): 6361-6373
- URL: https://www.wjgnet.com/2307-8960/full/v12/i30/6361.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i30.6361